Stock listing

Axsome Therapeutics, Inc.

Selected listing: A2AA7B · LS · EUR · DE

Axsome Therapeutics, Inc. (Lang & Schwarz: A2AA7B), Health Technology. Latest release Sep 21, 2026: Axsome Therapeutics Announces Results of the Shared Goals…

A2AA7B:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2AA7B
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Axsome Therapeutics, Inc.

Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day

September 21, 2026

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

September 17, 2026

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

August 31, 2026

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 10, 2026

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

July 15, 2026

All Axsome Therapeutics, Inc. news →

Events

Replays

Axsome Therapeutics, Inc. (AXSM) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 08:00 AM ET
Watch
Axsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call
Mon, May 04, 2026 · 08:00 AM ET
Watch
Axsome Therapeutics, Inc. (AXSM) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 08:00 AM ET
Watch

Research Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. company profile

View the public company page for Axsome Therapeutics, Inc. on 6ix.

Axsome Therapeutics, Inc. news

Read company news and market updates connected to Axsome Therapeutics, Inc..

Axsome Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Axsome Therapeutics, Inc..